CARGOCONNECT-NOVEMBER 2020 - Flipbook - Page 27
only. All temperature ranges
between -20°C to +25°C can be
offered including a dedicated
area for active containers. The
freezer is included in the three
temperature zones in Munich.
In Chicago, we upgraded
our existing warehouse, turning the facility into a state-ofthe-art pharma center with a
total capacity of 8600 sq ft dedicated for pharma shipments.
However, infrastructure is only
part of the equation; we have a
highly motivated crew serving our customers with the
best experience and top-class
lease elaborate more on
how you are preparing
to provide top-notch handling and logistics solutions.
The first step was to create
transparency and keep ourselves up to date with the constant information flow regarding the progress and development of COVID-19 vaccines.
Based on our findings, we
have put in place a task force
comprising of nine different
working groups. Special attention is given to the storage and
handling of frozen shipments,
temperature-controlled transportation on the tarmac, capacity and network adjustments,
to a name few. Simultaneously,
we maintain a very close dialogue with customers to align
our actions and optimise the
supply chain as a whole.
ny further initiatives
taken to maintain resiliency in overall air cargo
The transport of pharmaceuticals has always been one of
our top priorities. However we
felt, that it is necessary to create a COVID-19 task force in
order to cope with the expected challenges around the distribution of future vaccines.
First of all, the team is establishing transparency among
the product requirements, how
they may differ from current
cool supply chains, where
those vaccines are manufactured, and when distribution
is likely to commence.
lease throw light on the
present in the current
global pharma supply
chain. Tell us about how
the Lufthansa implements
innovative measures to
overcome them. What are
your recommendations for
the industry stakeholders?
One of the biggest challenges
in the current situation is the
lack of capacity due to contraction of belly freight. We at
Lufthansa Cargo have responded to the situation by
increasing the utilisation of
our freighters and introducing
so called ‘preighters’, slightly
modified passenger aircraft
used for transporting cargo.
In regards to cool chain specific weakness, we believe that
the industry needs to innovate
in the following three areas:
expansion of (pharma)
protection during tarmac
the entire transportation
Lufthansa Cargo is driving
these measures forward by
playing an active part in different IATA working groups.
t present, where should
more of the focus be?
In light of the global impact
COVID-19 has had, I believe
the industry has done a good
job in keeping up the global
supply chains. Having said
that, capacity limitations are
still an issue and the focus
should be placed on further
increasing the networks to accommodate returning demand
but also cope with the expected COVID-19 vaccine volumes.
Adequate investments into
cool chain capabilities as outlined before are a prerequisite.
will increase significantly, allowing joint actions to further
ow has the pandemic
COVID-19 is def i n itely a
booster for digitalisation. It
has strengthened and accelerated the trend to connect and
collaborate along the entire
Lufthansa Cargo accelerated key digitisation projects
during the pandemic such as
‘Rapid Rate Response’.
o you think India has
the potential to become a global pharma hub?
Both pharma facilities at Munich and Chicago
airports are providing our customers
with state-of-the-art infrastructure and
services that were built according to the CEIV
As we have arrived into the
‘new normal’, we need to review our actions once again
and implement measures to
ensure a more sustainable supply chain network in the future.
hat do you see as
the best emerging
practices in the pharma
supply chain in the wake of
I believe that stronger partnerships along the supply chain
and new digital solutions will
emerge as best practices during crises.
For instance, by sharing
operational data along the
supply chain, transparency
Not to question, India is already a global pharma hub!
India is often referred to as
the ‘pharmacy of the world’
and as such, it is one of the
top markets for us. India already contributes substant ia l ly for globa l gener ics
market, with Indian produc ts cont r ibut i ng over
40 per cent (by volume) of
US dr ugs a nd catering to
over 60 per cent of t he
We expect India to be one
of the major producing markets of COVID-19 vaccines,
which will further strengthen
India´s position as a global
pharma export nation.
CargoConnect november 2020 | 27